SANOFI S.A. - FR0000120578 (Stock)
Düsseldorf
| Price | Diff.% | Date & Time | Bid volume | Bid | Ask | Ask volume |
|---|---|---|---|---|---|---|
91,42 EUR
|
-0,8137% | 29.05.2025 19:53 | - | - | - | - |
| Contact | |
|---|---|
|
|
Sanofi 46, avenue de la Grande Armée 75017, Paris, FR |
| Phone | +33-1-53-77-40-00 |
| Fax | +33-1-53-77-44-03 |
| Internet | http://www.sanofi.com |
| IR Contact/PR Contact | -/- |
| Symbol | SANO |
| End of financial year | 31.12.2025 |
| Issued capital | 117.097.740.924,00 EUR |
| Shareholders | |
|---|---|
| Freefloat | 77,49% |
| L'Oréal SA | 7,19% |
| The Vanguard Group, Inc. | 3,42% |
| BlackRock Fund Advisors | 1,88% |
| Dodge & Cox | 1,82% |
| Capital Research & Management Co. (World Investors) | 1,68% |
| Amundi Asset Management SASU (Investment Management) | 1,45% |
| Sanofi | 1,32% |
| Capital International Ltd. | 1,27% |
| BlackRock Advisors (UK) Ltd. | 1,25% |
| Geode Capital Management LLC | 1,24% |
| Board | |
|---|---|
| Paul Hudson | Chairman of Managing Board |
| Roy Papatheodorou | Member of Executive Committee |
| Olivier Charmeil | Member of Executive Committee |
| Natalie Bickford | Member of Executive Committee |
| Madeleine Roach | Member of Executive Committee |
| Julie Van Ongevalle | Member of Executive Committee |
| Francois Roger | Member of Executive Committee |
| Emmanuel Frenehard | Member of Executive Committee |
| Brian Foard | Member of Executive Committee |
| Brendan O'Callaghan | Member of Executive Committee |
| Audrey Duval | Member of Executive Committee |
| Thomas Triomphe | Member of Executive Committee |
| Houman Ashrafian | Member of Executive Committee |
| Frédéric Oudéa | Chairman of Supervisory Board |
| Yann Tran | Member of Supervisory Board |
| Rachel Duan | Member of Supervisory Board |
| Patrick Kron | Member of Supervisory Board |
| Lise Kingo | Member of Supervisory Board |
| Fabienne Lecorvaisier | Member of Supervisory Board |
| Clotilde Delbos | Member of Supervisory Board |
| Christophe Babule | Member of Supervisory Board |
| Carole Ferrand | Member of Supervisory Board |
| Barbara Lavernos | Member of Supervisory Board |
| Anne-Francoise Nesmes | Member of Supervisory Board |
| Dr. Wolfgang Laux | Member of Supervisory Board |
| Activity Description |
|---|
|
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France. |
© 2000 - 2025 UniCredit Bank Austria AG. Please read our terms and conditions
Implemented and powered by FactSet
Fond data is provided from Mountain-View Data Gmbh
Austria-HomePage Version 2.0.54
